RSS feed

Publications by Aud Svindland

91 publications found

Original articles

Bergsland CH, Jeanmougin M, Moosavi SH, Svindland A, Bruun J, Nesbakken A, Sveen A, Lothe RA (2022)
Spatial analysis and CD25-expression identify regulatory T cells as predictors of a poor prognosis in colorectal cancer
Mod Pathol, 35 (9), 1236-1246
DOI 10.1038/s41379-022-01086-8, PubMed 35484226

Ouellet V, Erickson A, GAP1 UTMAs Contributing Investigators, Wiley K, Morrissey C, Berge V, Moreno CS, Tasken KA, Trudel D, True LD, Lewis MS, Svindland A, Ertunc O, Vidal ID, Osunkoya AO, Jones T, Bova GS, Lamminen T, Achtman AH, Buzza M, Kouspou MM, Bigler SA, Zhou X, Freedland SJ, Mes-Masson AM et al. (2022)
The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource
Cancer Epidemiol Biomarkers Prev, 31 (4), 715-727
DOI 10.1158/1055-9965.EPI-21-0600, PubMed 35131885

Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Mol Oncol, 16 (12), 2312-2329
DOI 10.1002/1878-0261.13159, PubMed 34890102

Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594

Ramberg H, Richardsen E, de Souza GA, Rakaee M, Stensland ME, Braadland PR, Nygård S, Ögren O, Guldvik IJ, Berge V, Svindland A, Taskén KA, Andersen S (2021)
Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer
Carcinogenesis, 42 (5), 685-693
DOI 10.1093/carcin/bgab015, PubMed 33609362

Lund T, Svindland A, Bay D, Sundhagen JO, Hisdal J, Flørenes T (2020)
Histological Analysis of a Long Term Patent Subintimal Canal in the Superficial Femoral Artery
EJVES Vasc Forum, 50, 19-23
DOI 10.1016/j.ejvsvf.2020.12.023, PubMed 33511376

Bergsland CH, Bruun J, Guren MG, Svindland A, Bjørnslett M, Smeby J, Hektoen M, Kolberg M, Domingo E, Pellinen T, Tomlinson I, Kerr D, Church DN, Nesbakken A, Sveen A, Lothe RA (2020)
Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
ESMO Open, 5 (6), e001040
DOI 10.1136/esmoopen-2020-001040, PubMed 33219056

Lopes N, Bergsland CH, Bjørnslett M, Pellinen T, Svindland A, Nesbakken A, Almeida R, Lothe RA, David L, Bruun J (2019)
Digital image analysis of multiplex fluorescence IHC in colorectal cancer recognizes the prognostic value of CDX2 and its negative correlation with SOX2
Lab Invest, 100 (1), 120-134
DOI 10.1038/s41374-019-0336-4, PubMed 31641225

Braadland PR, Ramberg H, Grytli HH, Urbanucci A, Nielsen HK, Guldvik IJ, Engedal A, Ketola K, Wang W, Svindland A, Mills IG, Bjartell A, Taskén KA (2019)
The β₂-Adrenergic Receptor Is a Molecular Switch for Neuroendocrine Transdifferentiation of Prostate Cancer Cells
Mol Cancer Res, 17 (11), 2154-2168
DOI 10.1158/1541-7786.MCR-18-0605, PubMed 31395667

Bruun J, Sveen A, Barros R, Eide PW, Eilertsen I, Kolberg M, Pellinen T, David L, Svindland A, Kallioniemi O, Guren MG, Nesbakken A, Almeida R, Lothe RA (2018)
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
Mol Oncol, 12 (9), 1639-1655
DOI 10.1002/1878-0261.12347, PubMed 29900672

Prencipe M, Fabre A, Murphy TB, Vargyas E, O'Neill A, Bjartell A, Tasken KA, Grytli HH, Svindland A, Berge V, Eri LM, Gallagher W, Watson RW (2018)
Role of serum response factor expression in prostate cancer biochemical recurrence
Prostate, 78 (10), 724-730
DOI 10.1002/pros.23516, PubMed 29608018

Danielsen HE, Hveem TS, Domingo E, Pradhan M, Kleppe A, Syvertsen RA, Kostolomov I, Nesheim JA, Askautrud HA, Nesbakken A, Lothe RA, Svindland A, Shepherd N, Novelli M, Johnstone E, Tomlinson I, Kerr R, Kerr DJ (2018)
Prognostic markers for colorectal cancer: estimating ploidy and stroma
Ann Oncol, 29 (3), 616-623
DOI 10.1093/annonc/mdx794, PubMed 29293881

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2018)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 118 (6), e11
DOI 10.1038/bjc.2017.470, PubMed 29462127

Braadland PR, Giskeødegård G, Sandsmark E, Bertilsson H, Euceda LR, Hansen AF, Guldvik IJ, Selnæs KM, Grytli HH, Katz B, Svindland A, Bathen TF, Eri LM, Nygård S, Berge V, Taskén KA, Tessem MB (2017)
Ex vivo metabolic fingerprinting identifies biomarkers predictive of prostate cancer recurrence following radical prostatectomy
Br J Cancer, 117 (11), 1656-1664
DOI 10.1038/bjc.2017.346, PubMed 28972967

Vedeld HM, Merok M, Jeanmougin M, Danielsen SA, Honne H, Presthus GK, Svindland A, Sjo OH, Hektoen M, Eknaes M, Nesbakken A, Lothe RA, Lind GE (2017)
CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
Int J Cancer, 141 (5), 967-976
DOI 10.1002/ijc.30796, PubMed 28542846

Bilir B, Sharma NV, Lee J, Hammarstrom B, Svindland A, Kucuk O, Moreno CS (2017)
Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
Int J Oncol, 51 (1), 223-234
DOI 10.3892/ijo.2017.4017, PubMed 28560383

Vatne K, Stensvold A, Myklebust TÅ, Møller B, Svindland A, Kvåle R, Fosså SD (2017)
Pre- and post-prostatectomy variables associated with pelvic post-operative radiotherapy in prostate cancer patients: a national registry-based study
Acta Oncol, 56 (10), 1295-1301
DOI 10.1080/0284186X.2017.1314006, PubMed 28422584

Walker SM, Knight LA, McCavigan AM, Logan GE, Berge V, Sherif A, Pandha H, Warren AY, Davidson C, Uprichard A, Blayney JK, Price B, Jellema GL, Steele CJ, Svindland A, McDade SS, Eden CG, Foster C, Mills IG, Neal DE, Mason MD, Kay EW, Waugh DJ, Harkin DP, Watson RW et al. (2017)
Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology
Eur Urol, 72 (4), 509-518
DOI 10.1016/j.eururo.2017.03.027, PubMed 28408174

Paur I, Lilleby W, Bøhn SK, Hulander E, Klein W, Vlatkovic L, Axcrona K, Bolstad N, Bjøro T, Laake P, Taskén KA, Svindland A, Eri LM, Brennhovd B, Carlsen MH, Fosså SD, Smeland SS, Karlsen AS, Blomhoff R (2016)
Tomato-based randomized controlled trial in prostate cancer patients: Effect on PSA
Clin Nutr, 36 (3), 672-679
DOI 10.1016/j.clnu.2016.06.014, PubMed 27406859

Ramberg H, Grytli HH, Nygård S, Wang W, Ögren O, Zhao S, Løvf M, Katz B, Skotheim RI, Bjartell A, Eri LM, Berge V, Svindland A, Taskén KA (2016)
PBX3 is a putative biomarker of aggressive prostate cancer
Int J Cancer, 139 (8), 1810-20
DOI 10.1002/ijc.30220, PubMed 27273830

Braadland PR, Grytli HH, Ramberg H, Katz B, Kellman R, Gauthier-Landry L, Fazli L, Krobert KA, Wang W, Levy FO, Bjartell A, Berge V, Rennie PS, Mellgren G, Mælandsmo GM, Svindland A, Barbier O, Taskén KA (2016)
Low β₂-adrenergic receptor level may promote development of castration resistant prostate cancer and altered steroid metabolism
Oncotarget, 7 (2), 1878-94
DOI 10.18632/oncotarget.6479, PubMed 26646591

Baco E, Rud E, Eri L, Oen G, Latkovic L, Svindland A, Eggesbø H, Ukimura O (2015)
[Not Available]
Prog Urol, 25 (13), 832-3
DOI 10.1016/j.purol.2015.08.231, PubMed 26544425

Bruun J, Kolberg M, Ahlquist TC, Røyrvik EC, Nome T, Leithe E, Lind GE, Merok MA, Rognum TO, Bjørkøy G, Johansen T, Lindblom A, Sun XF, Svindland A, Liestøl K, Nesbakken A, Skotheim RI, Lothe RA (2015)
Regulator of Chromosome Condensation 2 Identifies High-Risk Patients within Both Major Phenotypes of Colorectal Cancer
Clin Cancer Res, 21 (16), 3759-70
DOI 10.1158/1078-0432.CCR-14-3294, PubMed 25910952

Baco E, Rud E, Eri LM, Moen G, Vlatkovic L, Svindland A, Eggesbø HB, Ukimura O (2015)
A Randomized Controlled Trial To Assess and Compare the Outcomes of Two-core Prostate Biopsy Guided by Fused Magnetic Resonance and Transrectal Ultrasound Images and Traditional 12-core Systematic Biopsy
Eur Urol, 69 (1), 149-56
DOI 10.1016/j.eururo.2015.03.041, PubMed 25862143

Rud E, Baco E, Klotz D, Rennesund K, Svindland A, Berge V, Lundeby E, Wessel N, Hoff JR, Berg RE, Diep L, Eggesbø HB, Eri LM (2015)
Does preoperative magnetic resonance imaging reduce the rate of positive surgical margins at radical prostatectomy in a randomised clinical trial?
Eur Urol, 68 (3), 487-96
DOI 10.1016/j.eururo.2015.02.039, PubMed 25813692

Rud E, Klotz D, Rennesund K, Baco E, Berge V, Lien D, Svindland A, Lundeby E, Berg RE, Eri LM, Eggesbø HB (2014)
Detection of the index tumour and tumour volume in prostate cancer using T2-weighted and diffusion-weighted magnetic resonance imaging (MRI) alone
BJU Int, 114 (6b), E32-E42
DOI 10.1111/bju.12637, PubMed 24447606

Røe OD, Oppegaard PA, Revheim ME, Svindland A (2014)
Adrenocortical carcinoma mimicking lung cancer and responding to vinorelbine/carboplatin and pemetrexed/carboplatin
BMJ Case Rep, 2014
DOI 10.1136/bcr-2014-206225, PubMed 25391823

Baco E, Ukimura O, Rud E, Vlatkovic L, Svindland A, Aron M, Palmer S, Matsugasumi T, Marien A, Bernhard JC, Rewcastle JC, Eggesbø HB, Gill IS (2014)
Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients
Eur Urol, 67 (4), 787-94
DOI 10.1016/j.eururo.2014.08.077, PubMed 25240973

Baco E, Rud E, Ukimura O, Vlatkovic L, Svindland A, Matsugasumi T, Bernhard JC, Rewcastle JC, Eggesbø HB (2014)
Effect of targeted biopsy guided by elastic image fusion of MRI with 3D-TRUS on diagnosis of anterior prostate cancer
Urol Oncol, 32 (8), 1300-7
DOI 10.1016/j.urolonc.2014.07.014, PubMed 25189687

Baco E, Rud E, Vlatkovic L, Svindland A, Eggesbø HB, Hung AJ, Matsugasumi T, Bernhard JC, Gill IS, Ukimura O (2014)
Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer
J Urol, 193 (2), 466-72
DOI 10.1016/j.juro.2014.08.084, PubMed 25150643

Rud E, Klotz D, Rennesund K, Baco E, Johansen TE, Diep LM, Svindland A, Eri LM, Eggesbø HB (2014)
Preoperative magnetic resonance imaging for detecting uni- and bilateral extraprostatic disease in patients with prostate cancer
World J Urol, 33 (7), 1015-21
DOI 10.1007/s00345-014-1362-x, PubMed 25059766

Bruun J, Kolberg M, Nesland JM, Svindland A, Nesbakken A, Lothe RA (2014)
Prognostic Significance of β-Catenin, E-Cadherin, and SOX9 in Colorectal Cancer: Results from a Large Population-Representative Series
Front Oncol, 4, 118
DOI 10.3389/fonc.2014.00118, PubMed 24904831

Courivaud F, Kazaryan AM, Lund A, Orszagh VC, Svindland A, Marangos IP, Halvorsen PS, Jebsen P, Fosse E, Hol PK, Edwin B (2014)
Thermal fixation of swine liver tissue after magnetic resonance-guided high-intensity focused ultrasound ablation
Ultrasound Med Biol, 40 (7), 1564-77
DOI 10.1016/j.ultrasmedbio.2014.02.007, PubMed 24768489

Hveem TS, Merok MA, Pretorius ME, Novelli M, Bævre MS, Sjo OH, Clinch N, Liestøl K, Svindland A, Lothe RA, Nesbakken A, Danielsen HE (2014)
Prognostic impact of genomic instability in colorectal cancer
Br J Cancer, 110 (8), 2159-64
DOI 10.1038/bjc.2014.133, PubMed 24642618

Itkonen HM, Minner S, Guldvik IJ, Sandmann MJ, Tsourlakis MC, Berge V, Svindland A, Schlomm T, Mills IG (2013)
O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells
Cancer Res, 73 (16), 5277-87
DOI 10.1158/0008-5472.CAN-13-0549, PubMed 23720054

Merok MA, Ahlquist T, Røyrvik EC, Tufteland KF, Hektoen M, Sjo OH, Mala T, Svindland A, Lothe RA, Nesbakken A (2012)
Microsatellite instability has a positive prognostic impact on stage II colorectal cancer after complete resection: results from a large, consecutive Norwegian series
Ann Oncol, 24 (5), 1274-82
DOI 10.1093/annonc/mds614, PubMed 23235802

Steinsvik EA, Axcrona K, Angelsen A, Beisland C, Dahl A, Eri LM, Haug ES, Svindland A, Fosså S (2012)
Does a surgeon's annual radical prostatectomy volume predict the risk of positive surgical margins and urinary incontinence at one-year follow-up? Findings from a prospective national study
Scand J Urol, 47 (2), 92-100
DOI 10.3109/00365599.2012.707684, PubMed 22860630

Lazarevic B, Hammarström C, Yang J, Ramberg H, Diep LM, Karlsen SJ, Kucuk O, Saatcioglu F, Taskèn KA, Svindland A (2012)
The effects of short-term genistein intervention on prostate biomarker expression in patients with localised prostate cancer before radical prostatectomy
Br J Nutr, 108 (12), 2138-47
DOI 10.1017/S0007114512000384, PubMed 22397815

Sjo OH, Merok MA, Svindland A, Nesbakken A (2012)
Prognostic impact of lymph node harvest and lymph node ratio in patients with colon cancer
Dis Colon Rectum, 55 (3), 307-15
DOI 10.1097/DCR.0b013e3182423f62, PubMed 22469798

Sirnes S, Bruun J, Kolberg M, Kjenseth A, Lind GE, Svindland A, Brech A, Nesbakken A, Lothe RA, Leithe E, Rivedal E (2011)
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
Int J Cancer, 131 (3), 570-81
DOI 10.1002/ijc.26392, PubMed 21866551

Berge V, Berg RE, Hoff JR, Wessel N, Svindland A, Karlsen SJ, Eri LM (2011)
Five-year progression-free survival in 577 patients operated on with laparoscopic radical prostatectomy for localized prostate cancer
Scand J Urol Nephrol, 46 (1), 8-13
DOI 10.3109/00365599.2011.604790, PubMed 21843041

Lund T, Svindland A, Pepaj M, Jensen AB, Berg JP, Kilhovd B, Hanssen KF (2011)
Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans
Diab Vasc Dis Res, 8 (4), 284-94
DOI 10.1177/1479164111416831, PubMed 21844128

Ramberg H, Alshbib A, Berge V, Svindland A, Taskén KA (2011)
Regulation of PBX3 expression by androgen and Let-7d in prostate cancer
Mol Cancer, 10, 50
DOI 10.1186/1476-4598-10-50, PubMed 21548940

Sjo OH, Berg M, Merok MA, Kolberg M, Svindland A, Lothe RA, Nesbakken A (2011)
Peritoneal carcinomatosis of colon cancer origin: highest incidence in women and in patients with right-sided tumors
J Surg Oncol, 104 (7), 792-7
DOI 10.1002/jso.21959, PubMed 21547915

Faerden AE, Sjo OH, Bukholm IR, Andersen SN, Svindland A, Nesbakken A, Bakka A (2011)
Lymph node micrometastases and isolated tumor cells influence survival in stage I and II colon cancer
Dis Colon Rectum, 54 (2), 200-6
DOI 10.1007/DCR.0b013e3181fd4c7c, PubMed 21228669

Lazarevic B, Boezelijn G, Diep LM, Kvernrod K, Ogren O, Ramberg H, Moen A, Wessel N, Berg RE, Egge-Jacobsen W, Hammarstrom C, Svindland A, Kucuk O, Saatcioglu F, Taskèn KA, Karlsen SJ (2011)
Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
Nutr Cancer, 63 (6), 889-98
DOI 10.1080/01635581.2011.582221, PubMed 21714686

Nesbakken A, Kristinsson J, Svindland A, Lunde OC (2011)
Endoscopic snare resection followed by laser ablation in the treatment of large, sessile rectal adenomas
Scand J Surg, 100 (2), 99-104
DOI 10.1177/145749691110000206, PubMed 21737385

Kvåle R, Møller B, Wahlqvist R, Fosså SD, Berner A, Busch C, Kyrdalen AE, Svindland A, Viset T, Halvorsen OJ (2008)
Concordance between Gleason scores of needle biopsies and radical prostatectomy specimens: a population-based study
BJU Int, 103 (12), 1647-54
DOI 10.1111/j.1464-410X.2008.08255.x, PubMed 19154461

Seierstad SL, Svindland A, Larsen S, Rosenlund G, Torstensen BE, Evensen Ø (2008)
Development of intimal thickening of coronary arteries over the lifetime of Atlantic salmon, Salmo salar L., fed different lipid sources
J Fish Dis, 31 (6), 401-13
DOI 10.1111/j.1365-2761.2008.00913.x, PubMed 18471096

Kvissel AK, Ramberg H, Eide T, Svindland A, Skålhegg BS, Taskén KA (2006)
Androgen dependent regulation of protein kinase A subunits in prostate cancer cells
Cell Signal, 19 (2), 401-9
DOI 10.1016/j.cellsig.2006.07.011, PubMed 16949795

Larsen KO, Sjaastad I, Svindland A, Krobert KA, Skjønsberg OH, Christensen G (2006)
Alveolar hypoxia induces left ventricular diastolic dysfunction and reduces phosphorylation of phospholamban in mice
Am J Physiol Heart Circ Physiol, 291 (2), H507-16
DOI 10.1152/ajpheart.00862.2005, PubMed 16582020

Brandal P, Lie AK, Bassarova A, Svindland A, Risberg B, Danielsen H, Heim S (2006)
Genomic aberrations in mucinous tubular and spindle cell renal cell carcinomas
Mod Pathol, 19 (2), 186-94
DOI 10.1038/modpathol.3800499, PubMed 16258504

Taskén KA, Angelsen A, Svindland A, Eide T, Berge V, Wahlquist R, Karlsen S (2005)
[Markers for diagnosis, prediction and prognosis of prostate cancer]
Tidsskr Nor Laegeforen, 125 (23), 3279-82
PubMed 16327854

Seierstad SL, Poppe TT, Koppang EO, Svindland A, Rosenlund G, Frøyland L, Larsen S (2005)
Influence of dietary lipid composition on cardiac pathology in farmed Atlantic salmon, Salmo salar L
J Fish Dis, 28 (11), 677-90
DOI 10.1111/j.1365-2761.2005.00671.x, PubMed 16303029

Eliassen KA, Brodal BP, Svindland A, Osmundsen H, Rønning H, Djurovic S, Berg K (2005)
Activity of peroxisomal enzymes, and levels of polyamines in LPA-transgenic mice on two different diets
Lipids Health Dis, 4, 23
DOI 10.1186/1476-511X-4-23, PubMed 16202171

Korkmaz CG, Korkmaz KS, Kurys P, Elbi C, Wang L, Klokk TI, Hammarstrom C, Troen G, Svindland A, Hager GL, Saatcioglu F (2005)
Molecular cloning and characterization of STAMP2, an androgen-regulated six transmembrane protein that is overexpressed in prostate cancer
Oncogene, 24 (31), 4934-45
DOI 10.1038/sj.onc.1208677, PubMed 15897894

Teivainen PA, Eliassen KA, Berg K, Torsdalen K, Svindland A (2004)
Atherogenesis and vascular calcification in mice expressing the human LPA gene
Pathophysiology, 11 (2), 113-120
DOI 10.1016/j.pathophys.2004.06.007, PubMed 15364123

Storaas T, Gjesdal KI, Svindland A, Viktil E, Geitung JT (2004)
Dynamic first pass 3D EPI of the prostate: accuracy in tumor location
Acta Radiol, 45 (5), 584-90
DOI 10.1080/00365520410009357, PubMed 15515524

Jönsson-Rylander AC, Nordlander M, Svindland A, Ilebekk A (2003)
Distribution of neuropeptide Y Y1 and Y2 receptors in the postmortem human heart
Peptides, 24 (2), 255-62
DOI 10.1016/s0196-9781(03)00041-x, PubMed 12668210

Berg K, Svindland A, Smith AJ, Lawn RM, Djurovic S, Aleström A, Aleström P, Eliassen K (2002)
Spontaneous atherosclerosis in the proximal aorta of LPA transgenic mice on a normal diet
Atherosclerosis, 163 (1), 99-104
DOI 10.1016/s0021-9150(01)00772-9, PubMed 12048126

Saetre T, Höiby EA, Aspelin T, Lermark G, Egeland T, Svindland A, Lyberg T (2001)
Aminoethyl-isothiourea inhibits the increase in plasma endothelin-1 caused by serogroup A streptococci and prolongs survival in rat peritoneal sepsis
Shock, 15 (6), 446-52
DOI 10.1097/00024382-200115060-00006, PubMed 11386616

Eri LM, Svindland A, Tveter KJ (2001)
The effect of bicalutamide on prostate histology
Prostate, 46 (4), 275-80
DOI 10.1002/1097-0045(20010301)46:4<275::aid-pros1033>3.0.co;2-2, PubMed 11241549

Svindland A, Berg K, Eliassen K, Lawn RM, Djurovic S, Aleström P, Noren T, Smith A (2000)
Histopathology of arterial lesions in LPA transgenic mice on cholesterol-enriched chow
Atherosclerosis, 153 (2), 349-54
DOI 10.1016/s0021-9150(00)00430-5, PubMed 11164423

Eri LM, Svindland A (2000)
Can prostate epithelial content predict response to hormonal treatment of patients with benign prostatic hyperplasia?
Urology, 56 (2), 261-5
DOI 10.1016/s0090-4295(00)00629-4, PubMed 10925090

Hvaal K, Mathisen SR, Svindland A, Kirkeby OJ, Skjeldal S (1999)
Carvedilol reduces ischaemic skeletal muscle necrosis
J Orthop Res, 17 (5), 720-4
DOI 10.1002/jor.1100170515, PubMed 10569482

Kanellopoulos GK, Svindland A, Ilebekk A, Goverud I, Kvernebo K (1999)
Transventricular non-transmural laser treatment of hypoperfused porcine myocardium acutely reduces left ventricular contractile function
Eur J Cardiothorac Surg, 16 (2), 135-43
DOI 10.1016/s1010-7940(99)00169-4, PubMed 10485410

Hvaal K, Mathisen SR, Svindland A, Nordsletten L, Skjeldal S (1999)
Protective effect of the endothelin antagonist Bosentan against ischemic skeletal muscle necrosis
Acta Orthop Scand, 70 (3), 293-7
DOI 10.3109/17453679908997811, PubMed 10429609

Hvaal K, Oie E, Attramadal H, Halvorsen V, Svindland A, Nordsletten L, Skjeldal S (1998)
Endothelin-1 is upregulated during skeletal muscle ischemia and reperfusion
J Orthop Res, 16 (1), 128-35
DOI 10.1002/jor.1100160122, PubMed 9565085

Skjeldal S, Svindland A, Hvaal K, Kase T, Reikerås O, Nordsletten L (1997)
Severe hindlimb ischemia causes periosteal proliferation in the rat tibia
Acta Orthop Scand, 68 (6), 593-7
DOI 10.3109/17453679708999033, PubMed 9462363

Hvaal K, Svindland A, Nordsletten L, Skjeldal S (1996)
No increasing injury during early reperfusion of skeletal muscle
Scand J Clin Lab Invest, 56 (1), 11-6
DOI 10.3109/00365519609088582, PubMed 8850167

Svindland A, Eri LM, Tveter KJ (1996)
Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome
Scand. J. Urol. Nephrol., 30 179, 113-117

Svindland A, Eri LM, Tveter KJ (1996)
Morphometry of benign prostatic hyperplasia during androgen suppressive therapy. Relationships among epithelial content, PSA density, and clinical outcome
Scand J Urol Nephrol Suppl, 179, 113-7
PubMed 8908676

Haugen OA, Dalaker M, Svindland A (1994)
[Smuggling of narcotics in body cavities]
Tidsskr Nor Laegeforen, 114 (21), 2501-2
PubMed 7940455

Ellingsen O, Holthe MR, Svindland A, Aksnes G, Sejersted OM, Ilebekk A (1994)
Na,K-pump concentration in hypertrophied human hearts
Eur Heart J, 15 (9), 1184-90
DOI 10.1093/oxfordjournals.eurheartj.a060651, PubMed 7982417

Skjeldal S, Grøgaard B, Nordsletten L, Torvik A, Svindland A, Reikarås O (1994)
Does granulocyte depletion protect against ischaemic muscle necrosis?
Scand J Clin Lab Invest, 54 (1), 17-22
DOI 10.3109/00365519409086505, PubMed 8171267

Skjeldal S, Torvik A, Nordsletten L, Kirkeby OJ, Grøgaard B, Svindland A, Reikerås O (1993)
Local hypothermia during ischemia or reperfusion in skeletal muscles
Res Exp Med (Berl), 193 (2), 73-80
DOI 10.1007/BF02576213, PubMed 8516565

Lødrup KC, Svindland A, Refvem OK, Carlsen KH (1992)
[Sudden unexpected death and near death among children with asthma]
Tidsskr Nor Laegeforen, 112 (5), 620-2
PubMed 1557725

Skjeldal S, Grøgaard B, Nordsletten L, Reikerås O, Svindland A, Torvik A (1992)
Protective effect of low-grade hypothermia in experimental skeletal muscle ischemia
Eur Surg Res, 24 (4), 197-203
DOI 10.1159/000129207, PubMed 1505597

Skjeldal S, Grøgaard B, Reikerås O, Müller C, Torvik A, Svindland A (1991)
Model for skeletal muscle ischemia in rat hindlimb: evaluation of reperfusion and necrosis
Eur Surg Res, 23 (5-6), 355-65
DOI 10.1159/000129176, PubMed 1802740

Torvik A, Svindland A, Lindboe CF (1989)
Pathogenesis of carotid thrombosis
Stroke, 20 (11), 1477-83
DOI 10.1161/01.str.20.11.1477, PubMed 2815181

Svindland A, Torvik A (1988)
Atherosclerotic carotid disease in asymptomatic individuals: An histological study of 53 cases
Acta Neurol Scand, 78 (6), 506-17
DOI 10.1111/j.1600-0404.1988.tb03694.x, PubMed 3223238

Torvik A, Svindland A (1986)
Is there a transitional zone between brain infarcts and the surrounding brain? A histological study
Acta Neurol Scand, 74 (5), 365-70
DOI 10.1111/j.1600-0404.1986.tb03527.x, PubMed 3825494

Svindland A, Walløe L (1985)
Distribution pattern of sudanophilic plaques in the descending thoracic and proximal abdominal human aorta
Atherosclerosis, 57 (2-3), 219-24
DOI 10.1016/0021-9150(85)90035-8, PubMed 3841284

Svindland A (1984)
Localization of atherosclerotic lesions in three cerebral arterial bifurcations
Acta Pathol Microbiol Immunol Scand A, 92 (3), 177-83
DOI 10.1111/j.1699-0463.1984.tb04393.x, PubMed 6464761

Svindland A (1983)
The localization of sudanophilic and fibrous plaques in the main left coronary bifurcation
Atherosclerosis, 48 (2), 139-45
DOI 10.1016/0021-9150(83)90100-4, PubMed 6193799

Grøttum P, Svindland A, Walløe L (1983)
Localization of atherosclerotic lesions in the bifurcation of the main left coronary artery
Atherosclerosis, 47 (1), 55-62
DOI 10.1016/0021-9150(83)90071-0, PubMed 6870990

Grøttum P, Svindland A, Walløe L (1983)
Localization of early atherosclerotic lesions in the right carotid bifurcation in humans
Acta Pathol Microbiol Immunol Scand A, 91 (1), 65-70
DOI 10.1111/j.1699-0463.1983.tb02727.x, PubMed 6829313

Kjaernes M, Svindland A, Walløe L, Wille SO (1981)
Localization of early atherosclerotic lesions in an arterial bifurcation in humans
Acta Pathol Microbiol Scand A, 89 (1), 35-40
DOI 10.1111/j.1699-0463.1981.tb00184.x, PubMed 7013418

Book chapters

Storaas T, Gjesdal KI, Svindland A, Viktil E, Geitung JE (2004)
Dynamic first pass 3D EPI of the prostate: accuracy in tumor location
In Acta radiologica, Informa Helthcare, Stockholm, 45(2004)5, S. 584-90
BIBSYS 051856743

Jonsson-Rylander AC, Nordlander M, Svindland A, Ilebekk A (2003)
Distribution of neuropeptide Y Y1 and Y2 receptors in thepostmortem human heart
In Peptides, Elsevier, New York, 24(2003)2, s. 255-62
BIBSYS 041719220

Theses

Svindland A (1984)
Localization of atherosclerotic lesions in human arterialbifurcations
A. Svindland, Oslo, 1 b. (flere pag.)
BIBSYS 842096892